Skip to main content

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 525))

Abstract

GPCRs (G-protein coupled receptor) activation of extracellular signal- regulated kinases (ERK) has been extensively explored the last decade and showed a multitude of intracellular pathways involved including the activation of PKC, Ras, raf-1, etc [1]. Recently, it has been demonstrated that some GPCRs such as the lysophosphatidic acid, thrombin, bombesin and angiotensin receptor can activate ERK through the phosphorylation of the epidermal growth factor (EGF) receptor [[2]]. This was mainly done using selective inhibitors of the tyrosine kinase activity of the EGF receptor such as the tyrphostin AG1478. Also, direct demonstration of the phosphorylation of the receptor of EGF in response to these different ligands has been demonstrated [[3]].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal 1997; 9:337.

    Article  PubMed  CAS  Google Scholar 

  2. Zwick E, Hackel PO, Prenzel N, Ullrich A. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci 1999; 20:408.

    Article  PubMed  CAS  Google Scholar 

  3. Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A, Signal characteristics of G protein-transactivated EGF receptor. Embo J. 1997; 16:7032.

    Article  PubMed  CAS  Google Scholar 

  4. Armstrong RA, Wilson NH. Aspects of the thromboxane receptor system. Gen Pharmacol 1995; 26:463.

    Article  PubMed  CAS  Google Scholar 

  5. Jones DA., Benjamin CW, Linsema DA. Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades. Mol Pharmacol. 1995; 48:890.

    PubMed  CAS  Google Scholar 

  6. Karim S, Berrou E, Levy-Toledano S, Bryckaert M, MacLouf J. Regulatory role of prostaglandin E2 in induction of cyclo-oxygenase-2 by a thromboxane A2 analogue (U46619) and basic fibroblast growth factor in porcine aortic smooth-muscle cells. Biochem J 1997; 326:593.

    PubMed  CAS  Google Scholar 

  7. Heeneman S, Haendeler J, Saito Y, Ishida M, Berk BC. Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor b receptor. J Biol Chem 2000; 275:15926.

    Article  PubMed  CAS  Google Scholar 

  8. Eguchi S, Dempsey PJ, Frank GD, Motley ED, Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 2001; 276:7957.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gallet, C., Blaie, S., Lévy-Toledano, S., Habib, A. (2003). Thromboxane-Induced Erk Phosphorylation in Human Aortic Smooth Muscle Cells. In: Yazici, Z., Folco, G.C., Drazen, J.M., Nigam, S., Shimizu, T. (eds) Advances in Prostaglandin, Leukotriene, and other Bioactive Lipid Research. Advances in Experimental Medicine and Biology, vol 525. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9194-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9194-2_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4831-3

  • Online ISBN: 978-1-4419-9194-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics